Results 121 to 130 of about 964 (170)

Yellow nail syndrome linked to a mediastinal lipoma: a case report. [PDF]

J Med Case Rep
Müller C, Stricker I, Hykel P, Dellweg D.   +3 more
europepmc   +1 more source

Greenhouse Gas Emissions and Costs of Inhaler Devices in the US.

JAMA
Tirumalasetty J, Miller SA, Prescott HC, DeTata S, Arroyo AC, Wilkinson AJK, Rabin AS.   +6 more
europepmc   +1 more source

Implementation of a Metered-Dose Inhaler to Dry-Powder Inhaler National Formulary Transition.

JAMA Netw Open
Rabin AS, Weinstein JB, Whittington TN, Hogan CK, Khachikian D, Seelye SM, Prescott HC.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Olodaterol for the treatment of asthma

Expert Opinion on Investigational Drugs, 2016
Long-acting β-agonist (LABA)/inhaled corticosteroid (ICS) combinations are still the mainstay of asthma therapy but there is a pressing need to increase adherence to the prescribed treatment achievable in general by reducing the dose frequency. Consequently, there is considerable interest within the pharmaceutical industry in the discovery of once ...
Josuél Ora, Mario Cazzola
exaly   +3 more sources

Clinical improvement by tiotropium plus olodaterol [PDF]

Respiratory Medicine, 2017
Hiroaki Satoh
exaly   +3 more sources

Olodaterol + tiotropium bromide for the treatment of COPD

Expert Review of Respiratory Medicine, 2016
Patients suffering from COPD not controlled by a single bronchodilator should be given two bronchodilators with different mechanisms of action. Addition of a LABA to a LAMA induces a larger bronchodilation than that obtained with the LAMA as monotherapy and also improves many patient-reported outcomes.
Ermanno Puxeddu, Luigino Calzetta, Mario Cazzola   +2 more
exaly   +6 more sources

Olodaterol and vilanterol detection in sport drug testing

Drug Testing and Analysis, 2015
The possibility of the detection of olodaterol and vilanterol, two novel β2‐agonists, in human urine for the purpose of sport drug testing was investigated. Compounds of interest were analyzed by liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) employing methods commonly used in the World Anti‐Doping Agency (WADA) accredited laboratories.
Zdenek Chundela
exaly   +3 more sources

Tiotropium Bromide/Olodaterol Related Acute Cognitive Impairments

Case Reports in Clinical Medicine, 2023
Samer Alkhuja, Monika Girgis
exaly   +2 more sources

Olodaterol: First Global Approval

Drugs, 2013
Olodaterol (Striverdi(®) Respimat(®)) is a novel, long-acting, β2-adrenergic receptor agonist developed by Boehringer Ingelheim for the treatment of chronic obstructive pulmonary disease (COPD). The drug is delivered via the Respimat(®) Soft Mist™ inhaler. Olodaterol received its first global approval for the once-daily maintenance treatment of COPD in
Andrew, Gibb, Lily P H, Yang
openaire   +2 more sources